ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1216	46	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1116	finance.yahoo.com includes: Cash Position: $153.7 million in cash, cash equiva	luckydog88	2	August 5
1115	Cash reported was as of June 30, per press release. “The Company ended the quar	CCS648	1	July 25
1114	Have not seen 8K. If 157 was report as cash in quarterly earnings it would be b	Davidoff	-	July 25
1113	157M cash before offering?? any way to tell?	urslor	-	July 25
1112	Good ole Boral (EF Hutton) loves some IBRX @ $30. Hopefully someday soon he wil	Davidoff	1	July 25
1111	market agrees with you for now. but its been a few weeks since we got this :)	luckydog88	-	July 25
1110	While they need to raise cash, this appears more dilution at below market rates.	Davidoff	1	July 25
1109	now that they filed the 8-K, looks like they issued the shares at $2.70, with a	luckydog88	1	July 25
1108	Both hitting the wires this morning: ImmunityBio Reports 60% Increase in Revenu	luckydog88	1	July 25
1107	Couldn’t agree more!	jargonweary	-	July 24
1106		Olecranon	-	July 24
1105	Yes. Nice move on nice volume!	erippetoe	-	July 23
1104	Up 10.9% on 8.8MM shares vs. Average volume of 6.4MM. I would like to think the	TripleE3	1	July 23
1103	Los Angeles Times owner Patrick Soon-Shiong announced plans to take the 143-year	luckydog88	-	July 22
1102	Anktiva is an expensive life extending treatment. There is only a certain class	waitwatchwander	1	July 16
1101	To be clear, my post was not a comment one way or the other about the merits or	jargonweary	2	July 16
1100	Yes fundamentally they have to perform. Revenue must increase exponentially and	sukit	2	July 15
1099	It is painfully obvious that a strategy of photo ops with the president, flatter	jargonweary	6	July 15
1098	Megan Kelly, not exactly my idea of a credible source for expanding the merits	galt	5	July 14
1097	Latest interview of PSS by Megan Kelly x.com Summary by Grok: In the interview	End2War	3	July 11
1096	UK approval pr: ir.immunitybio.com	zagnut1	1	July 7
1095	New phase 1 study clinicaltrials.gov	mannamal	1	July 7
1094	This is good news primarily because it isn’t bad news. By that I mean that appr	jargonweary	-	July 6
1093	Maybe they wanted to get the biggest bang for their buck and put it out on Monda	zagnut1	-	July 6
1092	nothing on yahoo news and nothing reported on my Schwab account news.........	urslor	-	July 6

Go to reply# or date (mm/dd/yy):